Achelios Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series B
  • (Cancelled)

  • Latest Deal Amount
  • $11M

  • Investors
  • 3

Achelios Therapeutics General Information

Description

Developer of pharmaceutical products designed to reformulate non-steroidal anti-inflammatory drug molecules as topically delivered medications. The company's technology focuses on therapeutic compound development for the treatment of sprains, migraine prophylaxis, osteoarthritis, and strains by decreasing side effects and improving efficacy, enabling patients to receive faster and improved pain relief.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4364 South Alston Avenue
  • Suite 300
  • Durham, NC 27713
  • United States
+1 (919)
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • 4364 South Alston Avenue
  • Suite 300
  • Durham, NC 27713
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Achelios Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 01-Feb-2021 $11M Cancelled Clinical Trials - Phase 2
4. Later Stage VC (Series A1) 01-Oct-2020 Completed Clinical Trials - Phase 2
3. Debt - General 14-Apr-2020 Completed Clinical Trials - Phase 2
2. Seed Round 13-Mar-2014 $3.17M $5.17M Completed Clinical Trials - Phase 1
1. Capitalization 02-Feb-2012 $2M $2M Completed Pre-Clinical Trials
To view Achelios Therapeutics’s complete valuation and funding history, request access »

Achelios Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view Achelios Therapeutics’s complete cap table history, request access »

Achelios Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical products designed to reformulate non-steroidal anti-inflammatory drug molecules as topically
Drug Delivery
Durham, NC
6 As of 2021

Raritan, NJ
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Achelios Therapeutics Competitors (28)

One of Achelios Therapeutics’s 28 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
Pfizer (Vienna) Corporation Vienna, Austria
EnGeneIC Formerly VC-backed Sydney, Australia
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 28 competitors. Get the full list »

Achelios Therapeutics Patents

Achelios Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017325726-A1 Topical anti-inflammatory compositions Active 16-Sep-2016
AU-2017325726-B2 Topical anti-inflammatory compositions Active 16-Sep-2016
EP-3512498-A1 Topical anti-inflammatory compositions Active 16-Sep-2016
EP-3512498-A4 Topical anti-inflammatory compositions Active 16-Sep-2016
EP-3512498-B1 Topical anti-inflammatory compositions Active 16-Sep-2016 A61K31/196
To view Achelios Therapeutics’s complete patent history, request access »

Achelios Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Achelios Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Keiretsu Forum Angel Group Minority
K2X Venture Capital Minority
To view Achelios Therapeutics’s complete investors history, request access »

Achelios Therapeutics FAQs

  • When was Achelios Therapeutics founded?

    Achelios Therapeutics was founded in 2012.

  • Where is Achelios Therapeutics headquartered?

    Achelios Therapeutics is headquartered in Durham, NC.

  • What is the size of Achelios Therapeutics?

    Achelios Therapeutics has 6 total employees.

  • What industry is Achelios Therapeutics in?

    Achelios Therapeutics’s primary industry is Drug Delivery.

  • Is Achelios Therapeutics a private or public company?

    Achelios Therapeutics is a Private company.

  • What is the current valuation of Achelios Therapeutics?

    The current valuation of Achelios Therapeutics is .

  • What is Achelios Therapeutics’s current revenue?

    The current revenue for Achelios Therapeutics is .

  • How much funding has Achelios Therapeutics raised over time?

    Achelios Therapeutics has raised $24.7M.

  • Who are Achelios Therapeutics’s investors?

    , Keiretsu Forum, and K2X have invested in Achelios Therapeutics.

  • Who are Achelios Therapeutics’s competitors?

    Johnson&Johnson Innovative Medicine, Pfizer (Vienna), EnGeneIC, Dicerna Pharmaceuticals, and Genentech are some of the 28 competitors of Achelios Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process